Clinical Trials

A Phase III study of Fludarabine and Busulfan versus Fludarabine, Busulfan and low dose total body irradiation in patients receiving an allogeneic hematopoietic stem cell transplant


Study ID
HUMC Pro 00001278

NCT Number
NCT01366612 (Click on the NCT number for more information about the trial)

Research Study Number
00001278

Principle Investigator
Dr. Michele Donato

Phase
III

Sponsor
HackensackUMC


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now